Insurer Brain

Document:AXA/2025/FY/Earnings presentation: Difference between revisions

Browse history interactively
← Older editNewer edit →
Content deleted Content added
VisualWikitext
doc_archive: publish snjra2xp9r (original transcript) (.md link)
doc_archive: publish snjra2xp9r (original transcript)
Line 11:
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| wide = yes
| original_md = File:AXA<!-2025-FY ARCHIVE_MD_LINK_HERE -Earnings_presentation-original.md>
| docling_file = <!-- ARCHIVE_DOCLING_LINK_HERE -->
| article = AXA/2025/FY/Earnings presentation
| doc_id = snjra2xp9r
Line 20:
---
title: https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
source_file: tmpbnfh9baotmpgqqzyh7k.pdf
source_url: https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
doc_type: slides
Line 27:
converter: anchor_injection/1
tier: slides
parsed_at: '2026-07-22T1322T14:3416:39Z10Z'
scanned_pages: []
residue:
- '- February 26, 2026'
- Table of contents
- '- 4. Sustainability p.44'
---
ORIGINAL_FRONTMATTER -->
 
{{pdf page|1|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Full Year 2025 Earnings Presentation ===
 
* Full Year 2025
* Earnings Presentation
 
{{pdf page|2|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS AND THE USE OF NON-GAAP FINANCIAL MEASURES ===
 
* Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans, expectations or objectives, and other information that is not historical information. Forward-looking statements are generally identified by words and expressions such as "expects", "anticipates", "may", "plan," "target" or any variations or similar terminology of these words and expressions, or conditional verbs such as, without limitations, "would" and "could". In particular, the statements in this presentation regarding expected underlying earnings per share ("UEPS") growth for 2026 are forward-looking statements to provide one-off guidance in the context of the last year of the Group's current strategic plan. These statements in this presentation are based on Management's current views and intentions and are subject to change. Undue reliance should not be placed on forward-looking statements because, by their nature, they are subject to known and unknown risks and uncertainties, many of which are outside AXA's control, and can be affected by other factors that could cause AXA's actual results to differ materially from those expressed in, or implied or projected by, such forward-looking statements. Each forward-looking statement speaks only at the date of this presentation. Please refer to Part 5 - "Risk Factors and Risk Management" of AXA's Universal Registration Document for the year ended December 31, 2024 (the "2024 Universal Registration Document") for a description of certain important factors, risks and uncertainties that may affect AXA's business and/or results of operations. AXA specifically disclaims and undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as required by applicable laws and regulations.
* In addition, this presentation refers to certain non-GAAP financial measures, or alternative performance measures ("APMs"), used by Management in analyzing AXA's operating trends, financial performance and financial position and providing investors with additional information that Management believes to be useful and relevant regarding AXA's results. These non-GAAP financial measures generally have no standardized meaning and therefore may not be comparable to similarly labelled measures used by other companies. As a result, none of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS. "Underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio" and "debt gearing" are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015. AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology, as applicable) in its Activity Report as of December 31, 2025 ("AXA's 2025 Activity Report"), on the pages indicated under the heading "USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES". For further information on the above-mentioned and other non-GAAP financial measures used in this presentation, see the Glossary in AXA's 2025 Activity Report.
Line 45 ⟶ 51:
 
{{pdf page|3|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Table of contentsContents ===
* 1. FY25 Highlights p.04
* Thomas Buberl, Group CEO
Line 55 ⟶ 61:
{{pdf page|4|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
== FY25 Highlights ==
 
* Thomas Buberl, Group CEO
 
{{pdf page|5|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Full Year 2025 – Excellent performance ===
 
* +6% Revenues vs. FY24
* +8% Underlying EPS vs. FY24
* 16% ROE FY25
* 224% Solvency II ratio FY25
* Delivering value for shareholders: +8% DPS{{fn ref|1|2=Based on the dividend proposed by AXA’sAXA's Board of Directors on February 25, 2026 and subject to approval by the Shareholders’Shareholders' Annual General Meeting to be held on April 30, 2026.}} growth and €1.25bn annual share buy back{{fn ref|2|2=Following AXA’sAXA's Board of Directors’Directors' approval on February 25, 2026, and expected to commence as soon as reasonably practicable, subject to market conditions.}}
* Confident to deliver underlying EPS growth at the upper end of 6%-8% target range for 2026
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Based on the dividend proposed by AXA’sAXA's Board of Directors on February 25, 2026 and subject to approval by the Shareholders’Shareholders' Annual General Meeting to be held on April 30, 2026.}}
{{fn note|1=2|2=Following AXA’sAXA's Board of Directors’Directors' approval on February 25, 2026, and expected to commence as soon as reasonably practicable, subject to market conditions.}}
</div>
 
Line 76 ⟶ 84:
<div style="overflow-x:auto">
{| id="t1" class="wikitable fintable"
|+ Underlying earnings (In Euro billion)
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|}
</div>
 
+6% (* +9% excluding AXA IM)
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
 
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
* Scaling the business: Continued investments in growth and technology
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* Consistent earnings growth while enhancing reserve prudence
* Scaling the business: Continued investments in growth and technology
 
&#32;Consistent earnings growth while enhancing reserve prudence
 
<div class="ed-fn-notes" style="display:none">
Line 109 ⟶ 118:
<div style="overflow-x:auto">
{| id="t2" class="wikitable fintable"
|+ Pie chart represents FY25 gross written premium split excluding AXA IM and holdings.
|-
! style="text-align:left" | Business Segment
! class="col-s" style="text-align:right" | Share (%)
|-
| style="text-align:left" | Life
Line 137 ⟶ 146:
* Technical expertise to price & underwrite risks
* Scale offering cost advantage
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Pie chart represents FY25 gross written premium split excluding AXA IM and holdings.}}
</div>
 
{{pdf page|8|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
Line 149 ⟶ 162:
{{pdf page|9|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
== FY25 Business Performance ==
 
* Guillaume Borie
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology
Line 154 ⟶ 168:
{{pdf page|10|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Strong delivery across our businesses ===
 
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.
 
<div style="overflow-x:auto">
{| id="t3" class="wikitable"
|+ Gross written premiums and Underlying earnings
|-
! style="text-align:left" | Segment
! style="text-align:right" | Gross written premiums
! style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | France<br/> (27% of total GWP{{fn ref|1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}})
| style="text-align:right" | +6%<br/> to €31bn
| style="text-align:right" | +7%<br/> to €2.2bn
|-
| style="text-align:left" | Europe<br/> (38% of total GWP{{fn ref|1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}})
| style="text-align:right" | +6%<br/> to €43bn
| style="text-align:right" | +9%<br/> to €3.5bn
|-
| style="text-align:left" | AXA XL<br/> (17% of total GWP{{fn ref|1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}})
| style="text-align:right" | +4%<br/> to €19bn
| style="text-align:right" | +9%<br/> to €1.9bn
|-
| style="text-align:left" | Asia, Africa &amp; EME-LATAM<br/> (18% of total GWP{{fn ref|1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}})
| style="text-align:right" | +13%<br/> to €20bn
| style="text-align:right" | +6%<br/> to €1.5bn
|}
</div>
Line 187 ⟶ 204:
=== P&C – Strong margins, confidence in sustaining growth ===
 
* €58bn GWP
* GWP €58bn: Retail, SME & Mid-market, AXA XL{{fn ref|1|2=Includes AXA XL Re premiums of €2.6bn.}} (Large & Specialty)
* GWP mix: Retail, SME & Mid-market, AXA XL{{fn ref|1|2=Includes AXA XL Re premiums of €2.6bn.}} (Large & Specialty) — shares not printed
* Underlying earnings +9%{{fn ref|2|2=Change FY25 vs. FY24 at constant FX.}} to €5.9bn
 
*==== 2025 /and Beyond 2025: Strategy ====
* Retail and SME & Mid-market: Growing volumes while expanding margins (2025) | Investing to improve customer retention & expanding distribution footprint (Beyond 2025)
* AXA XL (Large & Specialty): Profitable growth with stable margins (2025) | Capitalizing on attractive growth opportunities and continued cycle management (Beyond 2025)
 
* Underlying earnings +9%{{fn ref|2|2=Change FY25 vs. FY24 at constant FX.}} to €5.9bn
 
* Retail and SME & Mid-market
* Continued progress on efficiency | Higher investment income | Data & AI to further enhance customer experience & technical excellence
* 2025: Growing volumes while expanding margins
* Beyond 2025: Investing to improve customer retention & expanding distribution footprint
* AXA XL (Large & Specialty)
* 2025: Profitable growth with stable margins
* Beyond 2025: Capitalizing on attractive growth opportunities and continued cycle management
* Continued progress on efficiency
* Higher investment income
* Data & AI to further enhance customer experience & technical excellence
 
<div class="ed-fn-notes" style="display:none">
Line 204 ⟶ 227:
{{pdf page|12|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== L&H – Good momentum, well positioned to capture growth opportunities ===
* GWP: €57bn (Short-term, Long-term — shares not printed)
 
* GWP: €57bn
2025 | Beyond 2025
* Short-term
* Long-term
* Underlying earnings: +7%{{fn ref|1|2=1. Change FY25 vs. FY24 at constant FX.}} to €3.5bn
 
==== Strategic Priorities ====
* Long-term business
* Accelerating net flows in Savings at attractive margins
* Capturing savings & retirement opportunity, sourcing best asset management products for our customers
 
<div style="overflow-x:auto">
* Short-term business
{| id="t4" class="wikitable"
* Growing technical results while absorbing Mexico VAT impact
|+ Strategic Priorities by Business Line
* Capitalizing on demand for health & protection while further improving our margins
|-
 
! style="text-align:left" |
* Underlying earnings +7%{{fn ref|1|2=Change FY25 vs. FY24 at constant FX.}} to €3.5bn
! style="text-align:left" | 2025
! style="text-align:left" | Beyond 2025
|-
| style="text-align:left" | Long-term business
| style="text-align:left" | Accelerating net flows in Savings at attractive margins
| style="text-align:left" | Capturing savings &amp; retirement opportunity, sourcing best asset management products for our customers
|-
| style="text-align:left" | Short-term business
| style="text-align:left" | Growing technical results while absorbing Mexico VAT impact
| style="text-align:left" | Capitalizing on demand for health &amp; protection while further improving our margins
|}
</div>
 
* Focus on cost reduction
* Increasing penetration of Protection riders in Savings offerings
* Leveraging AI to reduce claims leakage & improve customer outcomes in HealthcustomeroutcomesinHealth
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=1. Change FY25 vs. FY24 at constant FX.}}
</div>
 
{{pdf page|13|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
== FY25 Financial Performance ==
 
* Alban de Mailly Nesle
* Group CFO
Line 232 ⟶ 269:
{{pdf page|14|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== P&C – Continued disciplined growth ===
In Euro billion
 
==== GWP & Other Revenues ====
 
<div style="overflow-x:auto">
{| id="t4t5" class="wikitable fintable"
|+ GWP &amp; Other Revenues (in Euro billion)
|-
! style="text-align:left" |
Line 245 ⟶ 282:
! class="col-s" style="text-align:right" | o/w pricing{{fn ref|1|2=Price effect.}}
! class="col-s" style="text-align:right" | o/w volume{{fn ref|2|2=Includes exposure adjustments and mix &amp; other effects.}}
|-
| style="text-align:left" | Total
| style="text-align:right" | 56.5
| style="text-align:right" | 58.0
| style="text-align:right" | +5%
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Commercial lines
Line 266 ⟶ 310:
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|-
| style="text-align:left" | Total
| style="text-align:right" | 56.5
| style="text-align:right" | 58.0
| style="text-align:right" | +5%
| style="text-align:right" |
| style="text-align:right" |
|}
</div>
Line 281 ⟶ 318:
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
 
Change at constant scope and FX.
<div class="ed-fn-notes" style="display:none">
{{fn note|1=none|2=Change at constant scope and FX.}}
{{fn note|1=1|2=Price effect.}}
{{fn note|1=2|2=Includes exposure adjustments and mix & other effects.}}
Line 293 ⟶ 330:
 
<div style="overflow-x:auto">
{| id="t5t6" class="wikitable fintable"
|+ Combined ratio
|-
Line 299 ⟶ 336:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Combined ratio
| style="text-align:right" | 91.0%
| style="text-align:right" | 90.6%
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
Line 319 ⟶ 360:
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left" |
| style="text-align:right" | 91.0%
| style="text-align:right" | 90.6%
|}
</div>
Line 328 ⟶ 365:
* Better undiscounted current year loss ratio excluding Nat Cat from:
* Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
* Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Lower reliance on prior year reserve development
Line 337 ⟶ 374:
=== P&C – Earnings growth from higher underwriting and financial result ===
 
* In Euro million
 
==== Underlying Earnings ====
 
<div style="overflow-x:auto">
{| id="t6t7" class="wikitable fintable"
|+ Underlying Earnings (in Euro million)
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | In Euro million
|-
| style="text-align:left" | FY24
Line 358 ⟶ 394:
| style="text-align:right" | +435
|-
| style="text-align:left" | Insurance finance expenses
| style="text-align:right" | -235
|-
Line 369 ⟶ 405:
| style="text-align:left" | FY25
| style="text-align:right" | 5,872
|-
| style="text-align:left" | Change at constant FX
| style="text-align:right" | +9%
|}
</div>
 
* Better underwriting result{{fn ref|1|2=Underwriting result includes expenses.}} from strong volume growth and improved all-year combined ratio while enhancing reserve prudence
+9%
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets
 
* Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence
* Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets
* Higher unwind of discount of claims reserves, in line with guidance
* Unfavorable forex impact notably due to USD depreciation vs. EUR
 
Change at constant FX.
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Underwriting result includes expenses.}}
</div>
 
* Change at constant FX.
Full Year 2025 Earnings
* Full Year 2025 Earnings
 
{{pdf page|17|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
Line 390 ⟶ 427:
 
* In Euro billion
 
==== Life GWP & Other Revenues ====
 
<div style="overflow-x:auto">
{| id="t7t8" class="wikitable fintable"
|+ Life GWP &amp; Other Revenues
|-
! style="text-align:left" | (in Euro billion)
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Total
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
Line 412 ⟶ 442:
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-Linkedlinked
| style="text-align:right" |
| style="text-align:right" | 9.3
Line 426 ⟶ 456:
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left" | Total Life GWP &amp; Other Revenues
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|}
</div>
 
==== Health GWP & Other Revenues ====
 
<div style="overflow-x:auto">
{| id="t8t9" class="wikitable fintable"
|+ Health GWP &amp; Other Revenues
|-
! style="text-align:left" | (in Euro billion)
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Total
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|-
| style="text-align:left" | Individual
Line 454 ⟶ 482:
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left" | Total Health GWP &amp; Other Revenues
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|}
</div>
 
* o/w FY25 Employee Benefits{{fn ref|1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}} Euro 12.9 billion (+4% vs. FY24)
==== Net flows: €+5.4bn ====
 
* vs. €+1.5bn in FY24
 
<div style="overflow-x:auto">
{| id="t9t10" class="wikitable fintable"
|+ Net flows: €+5.4bn vs. €+1.5bn in FY24
|-
! style="text-align:left" | (in Euro billion)
! class="col-s" style="text-align:right" | €bnFY25
|-
| style="text-align:left" | Protection
Line 484 ⟶ 515:
|}
</div>
 
* o/w FY25 Employee Benefits{{fn ref|1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}} Euro 12.9 billion (+4% vs. FY24)
 
* Change at constant scope and FX.
Line 496 ⟶ 525:
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
 
* In Euro billion
PVEP
 
<div style="overflow-x:auto">
{| id="t10t11" class="wikitable fintable"
|+ PVEP
|-
! style="text-align:left" | (in Euro billion)
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change at constant scope and FX
|-
| style="text-align:left" | Protection &amp; Health
Line 526 ⟶ 556:
| style="text-align:right" | -10%
|-
| style="text-align:left" | Total PVEP
| style="text-align:right" | 50.9
| style="text-align:right" | 49.4
Line 533 ⟶ 563:
</div>
 
NB CSM (pre-tax)
<div style="overflow-x:auto">
{| id="t11t12" class="wikitable fintable"
|+ NB CSM (pre-tax)
|-
! style="text-align:left" | (in Euro billion)
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:rightleft" | Change at constant scope and FX
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:rightleft" | +3%
|}
</div>
 
NBV (post-tax)
<div style="overflow-x:auto">
{| id="t12t13" class="wikitable fintable"
|+ NBV (post-tax)
|-
! style="text-align:left" | (in Euro billion)
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:rightleft" | Change at constant scope and FX
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:rightleft" | stable
|}
</div>
 
NBV margin
<div style="overflow-x:auto">
{| id="t13" class="wikitable fintable"
|+ NBV margin
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:left" |
|}
</div>
Line 586 ⟶ 604:
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France
 
* Change at constant scope and FX.
 
{{pdf page|19|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Life & Health – Growth in new business driving Normalized CSM growth ===
 
* In Euro billion
* Normalized CSM growth +2%
* Normalized CSM up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates
* Economic variance reflecting government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland
* FX impact mainly from JPY and HKD depreciation
 
<div style="overflow-x:auto">
{| id="t14" class="wikitable fintable"
|+ Contractual Service Margin rollforward <br/> Normalized CSM growth +2%
|-
!| style="text-align:left" | In Euro billion
! class="col-s"| style="text-align:right" | ValueCSM
! class="col-s" style="text-align:right" | o/w Life
! class="col-s" style="text-align:right" | o/w Health
|-
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
|-
| style="text-align:left" | o/w Life
| style="text-align:right" | 25.8
|-
| style="text-align:left" | o/w Health
| style="text-align:right" | 7.7
|-
| style="text-align:left" | New business CSM
| style="text-align:right" | +2.2
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Underlying return on in-force
| style="text-align:right" | +1.3
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | CSM release
| style="text-align:right" | -3.0
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Economic variance
| style="text-align:right" | +0.6
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.3
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Affiliates, FX &amp; other
| style="text-align:right" | -1.4
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | FY25
| style="text-align:right" | 33.0
|-
| style="text-align:left" | o/w Life
| style="text-align:right" | 25.4
|-
| style="text-align:left" | o/w Health
| style="text-align:right" | 7.6
|}
</div>
 
* Change at constant scope and FX.
* Normalized CSM up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates
* Economic variance reflecting government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland
* FX impact mainly from JPY and HKD depreciation
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Change at constant scope and FX.}}
</div>
 
{{pdf page|20|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Life & Health – Strong momentum in both short-term and long-term business ===
 
In Euro million
 
==== Underlying Earnings ====
 
+7%
 
<div style="overflow-x:auto">
{| id="t15" class="wikitable fintable"
Line 688 ⟶ 697:
| style="text-align:right" | -728
|-
| style="text-align:left" | Underlying EarningsTotal
| style="text-align:right" | 3,323
| style="text-align:right" | +7%
Line 695 ⟶ 704:
</div>
 
in billions
Change at constant FX.
* o/w Life: 2.6 → 2.7, +4% vs. FY24
 
* o/w Health: 0.7 → 0.8, +17% vs. FY24
==== in billions ====
 
<div style="overflow-x:auto">
{| id="t16" class="wikitable fintable"
|+ in billions
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" | o/w Life
| style="text-align:right" | 2.6
| style="text-align:right" | 2.7
| style="text-align:right" | +4% vs. FY24
|-
| style="text-align:left" | o/w Health
| style="text-align:right" | 0.7
| style="text-align:right" | 0.8
| style="text-align:right" | +17% vs. FY24
|}
</div>
 
* Strong short-term technical margin reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (€-0.1bn)
* Higher long-term results from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins
 
Change at constant FX.
 
{{pdf page|21|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
* In Euro billion
 
<div style="overflow-x:auto">
{| id="t17t16" class="wikitable fintable"
|+ In Euro billion
|-
! style="text-align:left" |
Line 755 ⟶ 745:
| style="text-align:right" | -
|-
|! style="text-align:left" | Underlying earnings
|! class="col-s" style="text-align:right" | 8.1
|! class="col-s" style="text-align:right" | 8.4
|! class="col-s" style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
Line 775 ⟶ 765:
| style="text-align:right" |
|-
|! style="text-align:left" | Net income
|! class="col-s" style="text-align:right" | 7.9
|! class="col-s" style="text-align:right" | 9.8
|! class="col-s" style="text-align:right" | +26%
|}
</div>
Line 791 ⟶ 781:
==== Underlying earnings per share ====
<div style="overflow-x:auto">
{| id="t18t17" class="wikitable fintable"
|+ Underlying earnings per share In Euro
|-
! style="text-align:left" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings per share3.59
| style="text-align:right" | 3.59
| style="text-align:right" | 3.86
| style="text-align:right" | +8%
Line 807 ⟶ 795:
 
* +6% from earnings growth
* including -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback
* +3% from capital management
* -2% from forex
* including -1% from temporary earnings dilution from AXA IM sale due to the timing of anti-dilutive share buyback
 
<div class="ed-fn-notes" style="display:none">
Line 816 ⟶ 804:
 
{{pdf page|22|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Shareholders’Shareholders' Equity ===
 
* In Euro billion
 
==== Shareholders’Shareholders' equity{{fn ref|1|2=Shareholders’Shareholders' equity Group share. Full Year 2025 Earnings}} ====
 
<div style="overflow-x:auto">
{| id="t19t18" class="wikitable fintable"
|+ Shareholders' equity{{fn ref|1|2=Shareholders' equity Group share.}}
|+ Shareholders’ equity (in Euro billion)
|-
! style="text-align:left" |
Line 841 ⟶ 828:
| style="text-align:right" | -6.8
|-
| style="text-align:left" | Total Shareholders' equity
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
| style="text-align:left" | SHE (excl. OCI &amp; undated subordinated debt)
| style="text-align:right" | 53.2
| style="text-align:right" | 47.0
| style="text-align:right" | 49.4
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 23.4%
| style="text-align:right" | 22.3%
|-
| style="text-align:left" | Underlying ROE
| style="text-align:right" | 15.2%
| style="text-align:right" | 17.5%
| style="text-align:right" | 16.0%
|}
</div>
 
* SHE (excl. OCI & undated subordinated debt): 53.2 / 47.0 / 49.4
* Debt gearing: 20.6% / 23.4% / 22.3%
* Underlying ROE: 15.2% / 17.5% / 16.0%
 
<div style="overflow-x:auto">
{| id="t20t19" class="wikitable fintable"
|-
! style="text-align:left" | In Euro billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
Line 911 ⟶ 887:
|}
</div>
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Shareholders’Shareholders' equity Group share. Full Year 2025 Earnings}}
</div>
 
{{pdf page|23|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Higher organic cash remittance and robust cash position at Holding ===
In Euro billion
 
==== Net Cash Remittance ====
* In Euro billion
 
<div style="overflow-x:auto">
{| id="t21t20" class="wikitable fintable"
|+ Net Cash Remittance
|-
! style="text-align:left" |
Line 928 ⟶ 905:
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2|2=€0.6bn proceeds related to L&amp;S reinsurance in-force treaties at AXA France and AXA Life Europe.}}
| style="text-align:left" | Remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2|2=2. €0.6bn proceeds related to L&amp;S reinsurance in-force treaties at AXA France and AXA Life Europe.}}
| style="text-align:right" | 0.6
| style="text-align:right" |
|-
| style="text-align:left" | Ordinary cash remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Total
Line 940 ⟶ 917:
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Remittance ratio{{fn ref|1|2=1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.}}
| style="text-align:right" | 82%
| style="text-align:right" | 82%
|}
</div>
 
==== Cash Position Bridge ====
 
<div style="overflow-x:auto">
{| id="t22t21" class="wikitable fintable"
|-
|+ Cash Position Bridge
! style="text-align:left" |
! class="col-s" style="text-align:right" | In Euro billion
|-
| style="text-align:left" | FY24 Cash position
Line 974 ⟶ 955:
| style="text-align:right" | +3.1
|-
!| style="text-align:left" | FY25 Cash position
! class="col-s"| style="text-align:right" | 5.6
|}
</div>
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=1. Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.}}
{{fn note|1=2|2=2. €0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.}}
</div>
 
Line 988 ⟶ 969:
 
* In Euro billion
* Foreseeable dividends: €-4.8bn
* Provision for annual share buyback for 2026: €-1.25bn
 
<div style="overflow-x:auto">
{| id="t23t22" class="wikitable fintable"
|+ Eligible Own Funds (EOF) waterfall
|+ In Euro billion
|-
!| style="text-align:left" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Regulatory &amp; model changes
! class="col-s" style="text-align:right" | Normalized capital generation
! class="col-s" style="text-align:right" | Operating variance
! class="col-s" style="text-align:right" | Economic variance &amp; FX
! class="col-s" style="text-align:right" | Dividend &amp; annual share buyback
! class="col-s" style="text-align:right" | Management actions, debt &amp; other
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Eligible Own Funds (EOF)
| style="text-align:right" | 55.9
|-
| style="text-align:left" | Regulatory &amp; model changes
| style="text-align:right" | +0.2
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +8.8
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.4
|-
| style="text-align:left" | Economic variance &amp; FX
| style="text-align:right" | -2.1
|-
| style="text-align:left" | Dividend &amp; annual share buyback
| style="text-align:right" | -6.0
|-
| style="text-align:left" | Management actions, debt &amp; other
| style="text-align:right" | -0.1
|-
| style="text-align:left" | FY25
| style="text-align:right" | 56.4
|}
</div>
 
* Foreseeable dividends: €-4.8bn
* Provision for annual share buyback for 2026: €-1.25bn
 
<div style="overflow-x:auto">
{| id="t23" class="wikitable fintable"
|+ Solvency II ratio bridge
|-
| style="text-align:left" | Solvency II ratioFY24
| style="text-align:right" | 216%
|-
| style="text-align:left" | Regulatory &amp; model changes
| style="text-align:right" | +0pt
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +28pts
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -1pt
|-
| style="text-align:left" | Economic variance &amp; FX
| style="text-align:right" | +4pts
|-
| style="text-align:left" | Dividend &amp; annual share buyback
| style="text-align:right" | -24pts
|-
| style="text-align:left" | Management actions, debt &amp; other
| style="text-align:right" | +2pts
|-
| style="text-align:left" | FY25
| style="text-align:right" | 224%
|}
</div>
 
<div style="overflow-x:auto">
{| id="t24" class="wikitable fintable"
|+ Solvency Capital Requirement (SCR) waterfall
|-
| style="text-align:left" | Solvency Capital Requirement (SCR)FY24
| style="text-align:right" | 25.9
|-
| style="text-align:left" | Regulatory &amp; model changes
| style="text-align:right" | 0.0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | 0.0
|-
| style="text-align:left" | Economic variance &amp; FX
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Dividend &amp; annual share buyback
| style="text-align:right" | 0.0
|-
| style="text-align:left" | Management actions, debt &amp; other
| style="text-align:right" | -0.2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 25.2
|}
Line 1,040 ⟶ 1,066:
 
<div style="overflow-x:auto">
{| id="t24t25" class="wikitable fintable"
|+ Ratio as of December 31, 2025
|-
| style="text-align:left" | Ratio as of December 31, 2025
| style="text-align:right" | 224%
|-
Line 1,055 ⟶ 1,080:
| style="text-align:right" | -1 pt
|-
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1|2=1. Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).}}
| style="text-align:right" | -7 pts
|-
| style="text-align:left" | Credit migration{{fn ref|2|2=2. Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).}}
| style="text-align:right" | -4 pts
|-
| style="text-align:left" | Listed Equity (excl. PE &amp; Infra) +25%
| style="text-align:right" | -1+14 ptpts
|-
| style="text-align:left" | Listed Equity (excl. PE &amp; Infra) -25%
| style="text-align:right" | +2-19 pts
|-
| style="text-align:left" | PE &amp; Infra +25%
| style="text-align:right" | +142 pts
|-
| style="text-align:left" | PE &amp; Infra -25%
| style="text-align:right" | -191 ptspt
|-
| style="text-align:left" | Inflation swap curve +50bps
Line 1,079 ⟶ 1,104:
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=1. Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).}}
{{fn note|1=2|2=2. Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).}}
</div>
 
{{pdf page|25|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Solvency II – impact of the end of grandfathering period and Solvency II revision ===
 
* Ratio as of 31/12/2025: 224%
<div style="overflow-x:auto">
* Impact of the end of grandfathering period on January 1, 2026: -10pts to 215%
{| id="t26" class="wikitable fintable"
|-
! style="text-align:left" | Period/Impact
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Ratio
|-
| style="text-align:left" | Ratio as of 31/12/2025
| style="text-align:right" |
| style="text-align:right" | 224%
|-
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026
| style="text-align:right" | -10pts
| style="text-align:right" | 215%
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
| style="text-align:right" | +17pts{{fn ref|1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}
| style="text-align:right" |
|}
</div>
 
* Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026
* Impact of Solvency II revision to come into effect in 1Q27: +17pts{{fn ref|1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}
* No change expected in organic capital generation
* Additional capital flexibility
Line 1,098 ⟶ 1,142:
{{pdf page|26|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
== Conclusion ==
 
* Thomas Buberl, Group CEO
 
Line 1,109 ⟶ 1,154:
 
{{pdf page|28|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Q&A =Full Year 2025 Earnings ==
* Full Year 2025 Earnings
 
{{pdf page|29|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== AXA Investor Relations – Keep in touch ===
 
==== Meet our management ====
 
* March Roadshows Europe and US
* March: Roadshows - Europe and US
* May 5 1Q25 Activity Indicators Paris
* JuneMay 25: BNP1Q25 ParibasActivity ExaneIndicators CEO Conference- Paris
* June 2-4: GoldmanBNP SachsParibas EuropeanExane FinancialsCEO Conference Zurich- Paris
* June 2-4: Goldman Sachs European Financials Conference - Zurich
* July 31 HY26 Earnings Release Paris
* July 31: HY26 Earnings Release - Paris
* September 21 AXA Investor Day London
* September 21: AXA Investor Day - London
 
==== Contact us ====
 
* Investor Relations +33 1 40 75 48 42 investor.relations@axa.com
* Investor Relations
* +33 1 40 75 48 42
* investor.relations@axa.com
 
==== Follow us ====
 
* www.axa.com
 
Line 1,137 ⟶ 1,189:
{{pdf page|32|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
* In Euro billion
 
==== Gross financial debt{{fn ref|1,2}}¹'² ====
 
<div style="overflow-x:auto">
{| id="t25t27" class="wikitable fintable"
|+ Gross financial debt¹'² (inIn Euro billion) and Debt gearing
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026 <br/> End of the grandfathering period
|-
| style="text-align:left" | Debt gearing
| style="text-align:right" | 20.6%
| style="text-align:right" | 22.3%
| style="text-align:right" | -
|-
| style="text-align:left" | Tier 1
Line 1,167 ⟶ 1,215:
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8 {{fn ref|*|2=o/w €0.4bn redeemed in Jan 2026}}
|-
| style="text-align:left" | Total
Line 1,176 ⟶ 1,224:
</div>
 
* Debt gearing 20.6% FY24, 22.3% FY25
<div class="ed-fn-notes" style="display:none">
{{fn note|1=*|2= o/w €0.4bn redeemed in Jan 2026}}
* End of the grandfathering period
</div>
 
==== Contractual maturity breakdown ====
 
<div style="overflow-x:auto">
{| id="t26t28" class="wikitable fintable"
|+ Contractual maturity breakdown (inIn Euro billion)
|-
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
Line 1,198 ⟶ 1,246:
|-
| style="text-align:left" | Senior debt
| style="text-align:right" | -0.5
| style="text-align:right" | -
| style="text-align:right" | -
Line 1,205 ⟶ 1,253:
| style="text-align:right" | 0.9
| style="text-align:right" | 1.5
| style="text-align:right" | -0.5
| style="text-align:right" | -0.7
|-
| style="text-align:left" | Tier 2
Line 1,217 ⟶ 1,265:
| style="text-align:right" | -
| style="text-align:right" | 10.8
| style="text-align:right" | 04.76
|-
| style="text-align:left" | Tier 1
Line 1,228 ⟶ 1,276:
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 4.6-
|}
</div>
 
==== o/w Grandfathered debt ====
 
<div style="overflow-x:auto">
{| id="t29" class="wikitable fintable"
|+ o/w Grandfathered debt – Contractual maturity (In Euro billion)
|-
|! style="text-align:left" | o/w Grandfathered debt
|! class="col-s" style="text-align:right" | 2025
|! class="col-s" style="text-align:right" | 2026
|! class="col-s" style="text-align:right" | 2027
|! class="col-s" style="text-align:right" | 2028
|! class="col-s" style="text-align:right" | 2029
|! class="col-s" style="text-align:right" | 2030
|! class="col-s" style="text-align:right" | 2031-2039
|! class="col-s" style="text-align:right" | ≥2040
|! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" | Tier 1
Line 1,265 ⟶ 1,321:
</div>
 
==== Economic maturity breakdown³ ====
==== Economic maturity breakdown{{fn ref|3|2=Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.}} ====
 
<div style="overflow-x:auto">
{| id="t27t30" class="wikitable fintable"
|+ Economic maturity breakdown³ (inIn Euro billion)
|-
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | 2025
! class="col-s" style="text-align:right" | 2026
Line 1,284 ⟶ 1,340:
| style="text-align:left" | Senior debt
| style="text-align:right" | -
| style="text-align:right" | 0.1
| style="text-align:right" | -
| style="text-align:right" | 0.5
| style="text-align:right" | -
| style="text-align:right" | 0.9
| style="text-align:right" | 1.5
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.9
| style="text-align:right" | 1.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Tier 2
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 2.4-
| style="text-align:right" | 0.15
| style="text-align:right" | 2.0
| style="text-align:right" | 0.7
| style="text-align:right" | 6.4
| style="text-align:right" | -
| style="text-align:right" | 04.70
|-
| style="text-align:left" | Tier 1
| style="text-align:right" | -
| style="text-align:right" | 0.1
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | -
| style="text-align:right" | -
| style="text-align:right" | 0.4
| style="text-align:right" | -
| style="text-align:right" | -
|}
| style="text-align:right" | -
</div>
| style="text-align:right" | 0.4
 
| style="text-align:right" | 0.5
==== o/w Grandfathered debt ====
| style="text-align:right" | 4.0
 
<div style="overflow-x:auto">
{| id="t31" class="wikitable fintable"
|+ o/w Grandfathered debt – Economic maturity (In Euro billion)
|-
|! style="text-align:left" | o/w Grandfathered debt
|! class="col-s" style="text-align:right" | 2025
|! class="col-s" style="text-align:right" | 2026
|! class="col-s" style="text-align:right" | 2027
|! class="col-s" style="text-align:right" | 2028
|! class="col-s" style="text-align:right" | 2029
|! class="col-s" style="text-align:right" | 2030
|! class="col-s" style="text-align:right" | 2031-2039
|! class="col-s" style="text-align:right" | ≥2040
|! class="col-s" style="text-align:right" | Undated
|-
| style="text-align:left" | Tier 1
Line 1,344 ⟶ 1,408:
| style="text-align:right" | -
| style="text-align:right" | 0.7
| style="text-align:right" | -
| style="text-align:right" | 0.2
| style="text-align:right" | -
| style="text-align:right" | -
|}
Line 1,359 ⟶ 1,423:
=== General Account Invested Assets ===
 
====* FY25 Total General Account invested assets ====
* Duration gap at -0.4 year
* Euro 450 billion
* Invested assets mix:
 
* Fixed income
* Real estate
Line 1,372 ⟶ 1,436:
 
<div style="overflow-x:auto">
{| id="t28t32" class="wikitable fintable"
|+ Invested assets (100%) In Euro billion
|-
Line 1,391 ⟶ 1,455:
| style="text-align:right" | 27%
|-
| style="text-align:left" | o/w Other fixed income {{fn ref|1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial &amp; Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}}
| style="text-align:right" | 56
| style="text-align:right" | 13%
Line 1,403 ⟶ 1,467:
| style="text-align:right" | 2%
|-
| style="text-align:left" | Listed equities {{fn ref|2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}}
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Private equity and hedge funds {{fn ref|3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}}
| style="text-align:right" | 23
| style="text-align:right" | 5%
Line 1,419 ⟶ 1,483:
| style="text-align:right" | 0%
|-
|! style="text-align:left" | Total Insurance Invested Assets {{fn ref|4|2=Please refer to the financial supplement for more details.}}
|! class="col-s" style="text-align:right" | 450
|! class="col-s" style="text-align:right" | 100%
|}
</div>
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial &amp; Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}}
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}}
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}}
Line 1,436 ⟶ 1,500:
 
<div style="overflow-x:auto">
{| id="t29t33" class="wikitable fintable"
|+ Invested assets (100%) In Euro billion
|-
! style="text-align:left" | Invested assets (100%) In Euro billion
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A{{fn ref|1|2=G/A: General Account}} portfolio
Line 1,474 ⟶ 1,538:
| style="text-align:left" |
|-
|! style="text-align:left" | <b>Total Structured and Private Credit Assets</b>
|! class="col-s" style="text-align:right" | <b>69</b>
|! class="col-s" style="text-align:right" | <b>15%</b>
|! style="text-align:left" | o/w 54% participating
|}
</div>
Line 1,491 ⟶ 1,555:
 
<div style="overflow-x:auto">
{| id="t30t34" class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment (Total: Euro 57 billion)
|-
|! style="text-align:left" | Government bonds &amp; related (32%) – Average rating: AASegment
! class="col-s" style="text-align:right" | Share
! class="col-s" style="text-align:right" | Average rating
|-
| style="text-align:left" | Government bonds &amp; related
| style="text-align:right" | 32%
| style="text-align:right" | AA
|-
| style="text-align:left" | Investment grade credit (40%)- Average rating: A
| style="text-align:right" | 40%
| style="text-align:right" | A
|-
| style="text-align:left" | ABS/CLO/IG fund financing (21%)
| style="text-align:right" | 21%
| style="text-align:right" |
|-
| style="text-align:left" | Below investment grade credit (7%)
| style="text-align:right" | 7%
| style="text-align:right" |
|}
</div>
Line 1,511 ⟶ 1,583:
 
<div style="overflow-x:auto">
{| id="t31t35" class="wikitable fintable"
|-
! style="text-align:left" | Category
! class="col-s" style="text-align:right" | Yield
|-
Line 1,529 ⟶ 1,601:
* Euro 57 billion fixed income invested at 3.9%
* Average duration of 9 years
* Includes Euro 19.7 billion of Private &amp; Structured Credit invested at 4.7% (CLOs, ABS, Infra &amp; CRE debt, Fund financing and Private HY)
* Gradual shift from alternative total return assets to Private &amp; Structured credit
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Government and Corporate bonds and related.}}
{{fn note|1=2|2=Private &amp; Structured credit (CLOs, ABS, Infra &amp; CRE debt, Fund financing and Private hybrid).}}
</div>
 
* Full Year 2025 Earnings
 
{{pdf page|36|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
Line 1,547 ⟶ 1,617:
{{pdf page|37|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== AXA XL Insurance – Large Commercial & Specialty business ===
 
==== Well diversified across lines of business and geographies ====
 
<div style="overflow-x:auto">
{| id="t32t36" class="wikitable fintable"
|+ $19bn FY25 GWP by line of business
|-
! style="text-align:left" | Line of business
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Casualty
Line 1,561 ⟶ 1,636:
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines{{fn ref|1|2=Including Cyber;}}
| style="text-align:right" | 17%
|}
Line 1,567 ⟶ 1,642:
 
<div style="overflow-x:auto">
{| id="t33t37" class="wikitable fintable"
|+ $19bn FY25 GWP by geography
|-
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
Line 1,582 ⟶ 1,660:
 
==== Leading market positions across lines ====
 
* Top 3 globally
* Multinational Programs{{fn ref|2|2=Source: McKinsey;}}
* Marine{{fn ref|3|2=Source: Aon, Guy Carpenter, and Global Market Insights;}}
* Fine Art & Specie{{fn ref|4|2=Source: Industry Research Biz (January 2026).}}
 
==== Managing the cycle to deliver consistent profitability ====
 
* Profitability vs Ex-price growth (%):
* Profitability vs Ex-price growth (%) chart with bubbles for: Property, Specialty, Casualty, Professional lines
* Property
* Specialty
* Casualty
* Professional lines
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Including Cyber;}}
{{fn note|1=2|2=Source: McKinsey;}}
{{fn note|1=3|2=Source: Aon, Guy Carpenter, and Global Market Insights;}}
{{fn note|1=4|2=Source: Industry Research Biz (January 2026).}}
</div>
 
{{pdf page|38|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== P&C – Focus on Reserves ===
 
==== Claims reserves ratio ====
(Net undiscounted claims reserves/Net earned premiums)
 
<div style="overflow-x:auto">
{| id="t34t38" class="wikitable fintable"
|+ Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums)
|-
Line 1,631 ⟶ 1,711:
|}
</div>
 
==== Technical reserves ratio ====
(Net undiscounted technical reserves{{fn ref|1|2=Includes net undiscounted claims reserves and unearned premium reserves.}}/Net earned premiums)
 
<div style="overflow-x:auto">
{| id="t35t39" class="wikitable fintable"
|+ Technical reserves ratio (Net undiscounted technical reserves{{fn ref|1|2=Includes net undiscounted claims reserves and unearned premium reserves.}}/Net earned premiums)
|-
! colspan="5" style="text-align:center" | IFRS4
Line 1,666 ⟶ 1,749:
 
{{pdf page|39|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program{{fn ref|1|2=Excludes local reinsurance covers;}}¹ ===
 
In Euro
 
====* Insurance segment (occurrence protection) ====
* Reinsurance segment (illustrative)
* Alternative Capital & Cat Bonds
 
<div style="overflow-x:auto">
{| id="t36t40" class="wikitable fintable"
|+ P&amp;C &#124; 2026 Simplified Group Nat Cat Reinsurance Program¹ (In Euro)
|+ Insurance segment (occurrence protection)
|-
! style="text-align:left" | Peril
! class="col-s" style="text-align:right" | CapacityEU Windstorm
! class="col-s" style="text-align:right" | RetentionEurope Flood
! class="col-s" style="text-align:right" | Europe Earthquake
! class="col-s" style="text-align:right" | NA Hurricane
! class="col-s" style="text-align:right" | NA Earthquake
! class="col-s" style="text-align:right" | Per other perils³
|-
| style="text-align:left" | EU WindstormCapacity
| style="text-align:right" | 4.0bn
| style="text-align:right" | 600m
|-
| style="text-align:left" | Europe Flood
| style="text-align:right" | 2.1bn
| style="text-align:right" | 450m
|-
| style="text-align:left" | Europe Earthquake
| style="text-align:right" | 2.1bn
| style="text-align:right" | 400m
|-
| style="text-align:left" | NA Hurricane
| style="text-align:right" | 1.2bn
| style="text-align:right" | 600m{{fn ref|2|2=Varying retention between MX and NA (400m MX, 600m NA);}}
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 1.2bn
| style="text-align:right" | 600m{{fn ref|2|2=Varying retention between MX and NA (400m MX, 600m NA);}}1.2bn
|-
| style="text-align:left" | Retention
| style="text-align:left" | Per other perils{{fn ref|3|2=Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.}}
| style="text-align:right" | 1.2bn600m
| style="text-align:right" | 450m
| style="text-align:right" | 400m
| style="text-align:right" | 600m²
| style="text-align:right" | 600m²
| style="text-align:right" | 400m
|}
</div>
 
==== Reinsurance segment (illustrative) ====
 
* Alternative Capital & Cat Bonds
 
* Stable retention levels maintained in 2026 as in 2025
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=Excludes local reinsurance covers;}}
{{fn note|1=2|2=Varying retention between MX and NA (400m MX, 600m NA);}}
{{fn note|1=3|2=Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.}}
</div>
Line 1,721 ⟶ 1,798:
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost{{fn ref|1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance).}} in 2026 ===
 
* In Euro billion (net of reinsurance)
 
==== Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax ====
 
* net of reinsurance, post-tax net of reinsurance, pre-tax
* More severe years
 
* More severe years: Negative deviation in ca. 40% of cases
* Less severe years: Positive deviation in ca. 60% of cases
* Positive deviation in ca. 60% of cases
 
<div style="overflow-x:auto">
{| id="t37t41" class="wikitable"
|+ Group underlying earnings deviation to average Nat Cat charges in 2026 (net of reinsurance, post-tax)
|-
! style="text-align:left" | Return PeriodProbability
! style="text-align:right" | PercentileEarnings deviation
! style="text-align:right" | Deviation
|-
| style="text-align:left" | 1/20y (95th)
| style="text-align:right" | (5th)
| style="text-align:right" | €-1.2bn
|-
| style="text-align:left" | 1/10y (90th)
| style="text-align:right" | (10th)
| style="text-align:right" | €-0.8bn
|-
| style="text-align:left" | 1/5y (80th)
| style="text-align:right" | (20th)
| style="text-align:right" | €-0.4bn
|-
| style="text-align:left" | Median (50th)
| style="text-align:right" | (50th)
| style="text-align:right" | €+0.1bn
|-
| style="text-align:left" | 1/5y (20th)
| style="text-align:right" | (80th)
| style="text-align:right" | €+0.5bn
|-
| style="text-align:left" | 1/10y (10th)
| style="text-align:right" | (90th)
| style="text-align:right" | €+0.7bn
|-
| style="text-align:left" | 1/20y (5th)
| style="text-align:right" | (95th)
| style="text-align:right" | €+0.8bn
|}
</div>
 
==== Average Expected Nat Cat charges net of reinsurance, pre-tax ====
 
* net of reinsurance, pre-tax
 
<div style="overflow-x:auto">
{| id="t38t42" class="wikitable fintable"
|+ Average Expected Nat Cat charges (net of reinsurance, pre-tax)
|-
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | Charges (€bn)2025
! class="col-s" style="text-align:right" | Estimated impact on GEP2026
|-
| style="text-align:left" | 2025Average Expected Nat Cat charges
| style="text-align:right" | 2.6
| style="text-align:right" | ca. 4.5%
|-
| style="text-align:left" | 2026
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Estimated impact on GEP
| style="text-align:right" | ca. 4.5%
| style="text-align:right" | ca. 4.5%
|}
Line 1,794 ⟶ 1,866:
{{pdf page|41|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Contents ===
 
* 1. Debt and Invested Assets p.31
 
* 2. Additional P&C disclosures p.36
 
* 3. Additional IFRS17 disclosures p.41
 
* 4. Sustainability p.44
 
{{pdf page|42|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== P&C – Margin Analysis ===
 
* Changes versus FY24 at constant FX.
 
==== Technical Result ====
&#42;==== In Euro million (pre-tax)* ====
 
<div style="overflow-x:auto">
{| id="t39t43" class="wikitable fintable"
|+ Technical Result In Euro million (pre-tax)
|-
! style="text-align:left" |
Line 1,831 ⟶ 1,901:
| style="text-align:right" | 3.4%
| style="text-align:right" | -0.4pt
|}
</div>
 
<div style="overflow-x:auto">
{| id="t40" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Current Accident Year Discounting
Line 1,860 ⟶ 1,921:
| style="text-align:right" | 2.8%
| style="text-align:right" |
|}
</div>
 
<div style="overflow-x:auto">
{| id="t41" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Prior Years' Reserve Development (PYD)
Line 1,880 ⟶ 1,932:
</div>
 
* FY25 sensitivity to Current Accident Year discount rate changes{{fn ref|2|2=Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve.}}
* +25bps: €+0.2bn
* -25bps: €-0.2bn
 
==== Financial Result ====
&#42;==== In Euro million (pre-tax)* ====
 
<div style="overflow-x:auto">
{| id="t42t44" class="wikitable fintable"
|+ Financial Result In Euro million (pre-tax)
|-
! style="text-align:left" |
Line 1,906 ⟶ 1,959:
| style="text-align:right" |
|-
| style="text-align:left" | FY25 Reinvestment yield{{fn ref|1|2=Reinvestment yield on fixed income assets.}}
| style="text-align:right" | 4.3%
| style="text-align:right" |
|}
</div>
 
<div style="overflow-x:auto">
{| id="t43" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Insurance Finance Expenses
Line 1,933 ⟶ 1,977:
</div>
 
* 2026e Insurance Finance Expenses (pre-tax): ~ €-1.4bn
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount
* +25bps: ~ €-50m
* -25bps: ~ €+50m
 
<div style="overflow-x:auto">
{| id="t44t45" class="wikitable fintable"
|-
! style="text-align:left" |
Line 1,967 ⟶ 2,011:
</div>
 
<div class="ed-fn-notes" style="display:none">
Changes versus FY24 at constant FX. 1. Reinvestment yield on fixed income assets. 2. Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve.
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}
{{fn note|1=2|2=Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve.}}
</div>
 
{{pdf page|43|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
Line 1,974 ⟶ 2,021:
 
==== Technical Result ====
&#42;In Euro million, pre-tax*
 
<div style="overflow-x:auto">
{| id="t45t46" class="wikitable fintable"
|+ Short-term Technical ResultMargin
|-
! style="text-align:left" |
Line 1,995 ⟶ 2,042:
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.1pts
|}
</div>
 
* Incl. recapture of Laya
 
<div style="overflow-x:auto">
{| id="t47" class="wikitable fintable"
|+ Long-term Technical Margin
|-
|! style="text-align:left" | Incl. recapture of Laya
|! class="col-s" style="text-align:right" | FY25
|! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Long-term Technical Margin
Line 2,015 ⟶ 2,070:
 
==== Financial Result ====
&#42;In Euro million, pre-tax*
 
<div style="overflow-x:auto">
{| id="t46t48" class="wikitable fintable"
|+ Investment Income (non-VFA only)
|+ Financial Result
|-
! style="text-align:left" |
Line 2,040 ⟶ 2,095:
| style="text-align:right" | 3.8%
| style="text-align:right" |
|}
</div>
 
<div style="overflow-x:auto">
{| id="t49" class="wikitable fintable"
|+ Insurance Finance Expenses (non-VFA only)
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
Line 2,055 ⟶ 2,120:
</div>
 
<div style="overflow-x:auto">
==== Life & Health FY25 CSM Key Sensitivities ====
{| id="t50" class="wikitable fintable"
(in Euro billion)
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 4,229
| style="text-align:right" | +205
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | 65
|-
| style="text-align:left" | Affiliates, Minority interests &amp; Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|-
| style="text-align:left" | Growth vs. FY24 (at constant FX)
| style="text-align:right" |
| style="text-align:right" | +7%
|}
</div>
 
==== Life &amp; Health FY25 CSM Key Sensitivities ====
&#42;(in Euro billion)*
 
<div style="overflow-x:auto">
{| id="t47t51" class="wikitable fintable"
|-
|! style="text-align:left" | <b>Baseline</b>
|! class="col-s" style="text-align:right" | <b>33.3</b>
|-
| style="text-align:left" | Baseline
| style="text-align:right" | 33.3
|-
| style="text-align:left" | Interest rates +50bps
Line 2,087 ⟶ 2,184:
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
 
<div style="overflow-x:auto">
{| id="t48" class="wikitable fintable"
|-
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 4,229
| style="text-align:right" | +205
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | 65
|-
| style="text-align:left" | Affiliates, Minority interests &amp; Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|-
| style="text-align:left" | Growth vs. FY24 (at constant FX)
| style="text-align:right" |
| style="text-align:right" | +7%
|}
</div>
Line 2,122 ⟶ 2,190:
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}
</div>
 
* Changes versus FY24 at constant FX.
 
{{pdf page|44|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Table of contentsContents ===
* 1. Debt and Invested Assets p.31
* 2. Additional P&C disclosures p.36
Line 2,130 ⟶ 2,200:
 
{{pdf page|45|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Expanding AXA’sAXA's role in society: AXA for Progress Index{{fn ref|1|2=AXA’sAXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group’sGroup's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026.}} ===
 
==== As a GLOBAL INVESTOR ====
* Target
 
* €5bn{{fn ref|2|2=Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}} in climate transition financing per year
<div style="overflow-x:auto">
* >€500m{{fn ref|2|2=Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}} in community resilience financing per year
{| id="t49" class="wikitable"
* 2025 Result
|-
* €6.4bn
! style="text-align:left" | Target
* €1.4bn
! style="text-align:right" | 2025 Result
|-
| style="text-align:left" | €5bn{{fn ref|2|2=Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}}<br/> in climate transition financing per year
| style="text-align:right" | €6.4bn
|-
| style="text-align:left" | &gt;€500m{{fn ref|2|2=Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}}<br/> in community resilience financing per year
| style="text-align:right" | €1.4bn
|}
</div>
 
==== As a GLOBAL INSURER ====
* Target
 
* €6bn{{fn ref|3|2=Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.}} in P&C GWP to support transition underwriting (cumulative 2024-2026)
<div style="overflow-x:auto">
* >20,000{{fn ref|4|2=Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Climate solutions & services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaption solutions & services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from &gt;9,000 to &gt;20,000.}} climate adaptation solutions & services (cumulative 2024-2026) *Target revised in 2025*
{| id="t50" class="wikitable"
* >20m{{fn ref|5|2=Low-income to mass market segments in emerging markets and modest income segments in mature markets.}} inclusive insurance customers by 2026
|-
* 2025 Result
! style="text-align:left" | Target
* €4.6bn
! style="text-align:right" | 2025 Result
* 19,698 Cumulative 2024-2025
|-
* 20.6m
| style="text-align:left" | €6bn{{fn ref|3|2=Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK &amp; Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.}}<br/> in P&amp;C GWP to support transition underwriting (cumulative 2024-2026)
| style="text-align:right" | €4.6bn
|-
| style="text-align:left" | &gt;20,000{{fn ref|4|2=Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Climate solutions &amp; services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaption solutions &amp; services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from &gt;9,000 to &gt;20,000.}}<br/> climate adaptation solutions &amp; services (cumulative 2024-2026)<br/> Target revised in 2025
| style="text-align:right" | 19,698<br/>Cumulative 2024-2025
|-
| style="text-align:left" | &gt;20m{{fn ref|5|2=Low-income to mass market segments in emerging markets and modest income segments in mature markets.}}<br/> inclusive insurance customers by 2026
| style="text-align:right" | 20.6m
|}
</div>
 
==== As a COMPANY ====
* Target
 
* >80,000{{fn ref|6|2=Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}} AXA Group employees trained on climate adaptation by 2026
<div style="overflow-x:auto">
* Contribute to Net-Zero -50%{{fn ref|7|2=Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030 in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}}
{| id="t51" class="wikitable fintable"
* 50% Percentage of AXA Group employees engaged in volunteering activities by 2026
|-
* 2025 Result
! style="text-align:left" | Target
* 46,420
! class="col-m" style="text-align:right" | 2025 Result
* -64% Reduction against 2019
|-
* 56%
| style="text-align:left" | &gt;80,000{{fn ref|6|2=Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.}}<br/> AXA Group employees trained on climate adaptation by 2026
| style="text-align:right" | 46,420
|-
| style="text-align:left" | Contribute to Net-Zero<br/> -50%{{fn ref|7|2=Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.}} by 2030<br/> in absolute carbon emissions and offset of residual emissions{{fn ref|8|2=Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).}}
| style="text-align:right" | -64%<br/>Reduction against 2019
|-
| style="text-align:left" | 50% Percentage of AXA Group employees engaged in volunteering activities by 2026
| style="text-align:right" | 56%
|}
</div>
 
<div class="ed-fn-notes" style="display:none">
{{fn note|1=1|2=AXA’sAXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group’sGroup's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026.}}
{{fn note|1=2|2=Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.}}
{{fn note|1=3|2=Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.}}
Line 2,199 ⟶ 2,244:
=== Sustainability Performance & Ratings ===
 
* S&P Global: 2025 percentile: 97th {{fn ref|1|2=The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.}} in Dow Jones Best-in-Class Europe & World indices
* MSCI: 2025 score: AAA
* CDP: 2025 score: B
* MORNINGSTAR SUSTAINALYTICS: 2025 ESG Risk Rating: 17.0– Low risk
* FTSE RUSSELL An LSEG Business: 2025 score: 4.3/5 in FTSE4Good Index Series
 
<div class="ed-fn-notes" style="display:none">
Line 2,211 ⟶ 2,256:
{{pdf page|47|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Scope ===
 
* France: includes insurance activities, banking activities and holding.
* Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities) and AXA Life Europe (insurance activities).
Line 2,217 ⟶ 2,263:
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings.
* AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method.
 
* * Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023. Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9*
* Unless otherwise specified herein, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023. Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9
 
{{pdf page|48|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
Line 2,226 ⟶ 2,273:
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder'sshareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow
* Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business). Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities)
* New Business Value (NBV): the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests
Line 2,238 ⟶ 2,285:
{{pdf page|49|url=https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf}}
=== Thank you ===
 
* Full Year 2025 Earnings
Retrieved from "https://www.insurerbrain.com/wiki/Document:AXA/2025/FY/Earnings_presentation"